These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 30013815)

  • 1. Combination Phentermine-Topiramate Extended Release for the Treatment of Binge Eating Disorder: An Open-Label, Prospective Study.
    Guerdjikova AI; Williams S; Blom TJ; Mori N; McElroy SL
    Innov Clin Neurosci; 2018 Jun; 15(5-6):17-21. PubMed ID: 30013815
    [No Abstract]   [Full Text] [Related]  

  • 2. Study protocol and rationale for a randomized double-blinded crossover trial of phentermine-topiramate ER versus placebo to treat binge eating disorder and bulimia nervosa.
    Dalai SS; Adler S; Najarian T; Safer DL
    Contemp Clin Trials; 2018 Jan; 64():173-178. PubMed ID: 29038069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized, placebo-controlled crossover trial of phentermine-topiramate ER in patients with binge-eating disorder and bulimia nervosa.
    Safer DL; Adler S; Dalai SS; Bentley JP; Toyama H; Pajarito S; Najarian T
    Int J Eat Disord; 2020 Feb; 53(2):266-277. PubMed ID: 31721257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebo-controlled, phase 3 trial.
    Gadde KM; Allison DB; Ryan DH; Peterson CA; Troupin B; Schwiers ML; Day WW
    Lancet; 2011 Apr; 377(9774):1341-52. PubMed ID: 21481449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topiramate in the long-term treatment of binge-eating disorder associated with obesity.
    McElroy SL; Shapira NA; Arnold LM; Keck PE; Rosenthal NR; Wu SC; Capece JA; Fazzio L; Hudson JI
    J Clin Psychiatry; 2004 Nov; 65(11):1463-9. PubMed ID: 15554757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topiramate in the treatment of binge eating disorder associated with obesity: a randomized, placebo-controlled trial.
    McElroy SL; Arnold LM; Shapira NA; Keck PE; Rosenthal NR; Karim MR; Kamin M; Hudson JI
    Am J Psychiatry; 2003 Feb; 160(2):255-61. PubMed ID: 12562571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phentermine-topiramate extended release for the dual treatment of obesity and sleep-related eating disorder: a case report.
    Grunvald E; DeConde J
    J Med Case Rep; 2022 Jan; 16(1):34. PubMed ID: 35081980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of binge-eating disorder with topiramate: a clinical case series.
    Shapira NA; Goldsmith TD; McElroy SL
    J Clin Psychiatry; 2000 May; 61(5):368-72. PubMed ID: 10847312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A review of the metabolic effects of controlled-release Phentermine/Topiramate.
    Kiortsis DN
    Hormones (Athens); 2013; 12(4):507-16. PubMed ID: 24457398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Double-blind, randomized, placebo-controlled trial of topiramate plus cognitive-behavior therapy in binge-eating disorder.
    Claudino AM; de Oliveira IR; Appolinario JC; Cordás TA; Duchesne M; Sichieri R; Bacaltchuk J
    J Clin Psychiatry; 2007 Sep; 68(9):1324-32. PubMed ID: 17915969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SipNose-topiramate: a potential novel approach to binge eating management.
    Kobo-Greenhut A; Zohar-Beja A; Hadar L; Itzhaki L; Karasik A; Caraco Y; Frankenthal H; Shahaf D; Ekstein D; Shichor I; Gur E
    J Eat Disord; 2023 Jun; 11(1):102. PubMed ID: 37365668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Zonisamide in the treatment of binge-eating disorder: an open-label, prospective trial.
    McElroy SL; Kotwal R; Hudson JI; Nelson EB; Keck PE
    J Clin Psychiatry; 2004 Jan; 65(1):50-6. PubMed ID: 14744168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and Safety of Phentermine/Topiramate in Adults with Overweight or Obesity: A Systematic Review and Meta-Analysis.
    Lei XG; Ruan JQ; Lai C; Sun Z; Yang X
    Obesity (Silver Spring); 2021 Jun; 29(6):985-994. PubMed ID: 33864346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of phentermine-topiramate extended release in combination with sleeve gastrectomy in patients with BMI 50 kg/m
    Ard JD; Beavers DP; Hale E; Miller G; McNatt S; Fernandez A
    Surg Obes Relat Dis; 2019 Jul; 15(7):1039-1043. PubMed ID: 31147285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phentermine and topiramate extended-release: a new treatment for obesity and its role in a complications-centric approach to obesity medical management.
    Garvey WT
    Expert Opin Drug Saf; 2013 Sep; 12(5):741-56. PubMed ID: 23738843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phentermine/topiramate for the treatment of obesity.
    Smith SM; Meyer M; Trinkley KE
    Ann Pharmacother; 2013 Mar; 47(3):340-9. PubMed ID: 23482732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of phentermine / topiramate extended-release, phentermine, and placebo on ambulatory blood pressure monitoring in adults with overweight or obesity: A randomized, multicenter, double-blind study.
    Bays HE; Hsia DS; Nguyen LT; Peterson CA; Varghese ST
    Obes Pillars; 2024 Mar; 9():100099. PubMed ID: 38304225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Observational Comparative Effectiveness of Pharmaceutical Treatments for Obesity within the Veterans Health Administration.
    Grabarczyk TR
    Pharmacotherapy; 2018 Jan; 38(1):19-28. PubMed ID: 29044720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination phentermine and topiramate extended release in the management of obesity.
    Alfaris N; Minnick AM; Hopkins CM; Berkowitz RI; Wadden TA
    Expert Opin Pharmacother; 2015 Jun; 16(8):1263-74. PubMed ID: 25958964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Innovative Disease-Drug-Trial Framework to Guide Binge Eating Disorder Drug Development: A Case Study for Topiramate.
    Kalaria SN; McElroy SL; Gobburu J; Gopalakrishnan M
    Clin Transl Sci; 2020 Jan; 13(1):88-97. PubMed ID: 31386273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.